ID

37325

Beskrivning

Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine; ODM derived from: https://clinicaltrials.gov/show/NCT02200991

Länk

https://clinicaltrials.gov/show/NCT02200991

Nyckelord

Versioner (1)
  1. 2019-07-17 2019-07-17 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

17 juli 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Type 2 Diabetes Mellitus NCT02200991

Engelsk

Eligibility Type 2 Diabetes Mellitus NCT02200991

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus, treated with lantus±su; ≥5-year after diagnosis
Beskrivning

Non-Insulin-Dependent Diabetes Mellitus Disease length | Lantus | Sulfonylurea

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
UMLS CUI [2]
C0876064
UMLS CUI [3]
C3536898
aged 20-75 years
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
hemoglobin a1c ≥7.0%-≤10.0%
Beskrivning

Hemoglobin A1c measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0474680
fasting plasma glucose ≤180 mg/dl at screening
Beskrivning

Plasma fasting glucose measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0583513
stable treatment (±20%) with lantus for 3 months or more prior to screening.
Beskrivning

Lantus Stable status

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0876064
UMLS CUI [1,2]
C0205360
sulfonylurea dose stable for 3 months or more prior to screening
Beskrivning

Sulfonylurea Dose Stable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3536898
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes mellitus
Beskrivning

Diabetes Mellitus, Insulin-Dependent

Datatyp

boolean

Alias
UMLS CUI [1]
C0011854
pregnancy or lactation
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
hypersensitivity to lixisenatide
Beskrivning

Hypersensitivity Lixisenatide

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2973895
severely uncontrolled glycemic situation
Beskrivning

Blood Glucose Uncontrolled Severe

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0005802
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0205082
history of unexplained pancreatitis, chronic pancreatitis, pancreatectomy, stomach/gastric surgery or inflammatory bowel disease
Beskrivning

Pancreatitis Unexplained | Pancreatitis, Chronic | Pancreatectomy | Operation on stomach | Inflammatory Bowel Disease

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0030305
UMLS CUI [1,2]
C4288071
UMLS CUI [2]
C0149521
UMLS CUI [3]
C0030279
UMLS CUI [4]
C0192398
UMLS CUI [5]
C0021390
history of metabolic acidosis, including diabetic ketoacidosis, within 1 year prior to screening
Beskrivning

Metabolic acidosis | Diabetic Ketoacidosis

Datatyp

boolean

Alias
UMLS CUI [1]
C0220981
UMLS CUI [2]
C0011880
history within the previous 6 months of myocardial infarction, stroke or heart failure requiring hospitalization or drug or alcohol abuse
Beskrivning

Myocardial Infarction | Cerebrovascular accident | Heart failure Requirement Hospitalization | Substance Use Disorders

Datatyp

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0038454
UMLS CUI [3,1]
C0018801
UMLS CUI [3,2]
C1514873
UMLS CUI [3,3]
C0019993
UMLS CUI [4]
C0038586
uncontrolled/inadequately controlled hypertension at the time of screening, with a resting systolic blood pressure >180 mmhg or diastolic blood pressure >95 mmhg
Beskrivning

Uncontrolled hypertension | Poor hypertension control | Systolic blood pressure at rest | Diastolic blood pressure at rest

Datatyp

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0421190
UMLS CUI [3]
C2039694
UMLS CUI [4]
C2183311
amylase and/or lipase >3 times or aspartate aminotransferase (ast), alanine aminotransferase (alt) or alkaline phosphatase (alp) >2 times the upper limit of the normal laboratory range
Beskrivning

Serum amylase raised | Serum lipase raised | Aspartate aminotransferase increased | Alanine aminotransferase increased | Serum alkaline phosphatase raised

Datatyp

boolean

Alias
UMLS CUI [1]
C0476327
UMLS CUI [2]
C3670924
UMLS CUI [3]
C0151904
UMLS CUI [4]
C0151905
UMLS CUI [5]
C1314665
end-stage renal disease and/or dialysis and clinically relevant history of gastrointestinal disease
Beskrivning

Kidney Failure, Chronic | Dialysis | Gastrointestinal Diseases

Datatyp

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2]
C0011946
UMLS CUI [3]
C0017178
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial
Beskrivning

Study Subject Participation Status | Considerations Additional

Datatyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0518609
UMLS CUI [2,2]
C1524062
Tillbaka till toppen

Similar models

Eligibility Type 2 Diabetes Mellitus NCT02200991

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Disease length | Lantus | Sulfonylurea
Item
type 2 diabetes mellitus, treated with lantus±su; ≥5-year after diagnosis
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0876064 (UMLS CUI [2])
C3536898 (UMLS CUI [3])
Age
Item
aged 20-75 years
boolean
C0001779 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hemoglobin a1c ≥7.0%-≤10.0%
boolean
C0474680 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fasting plasma glucose ≤180 mg/dl at screening
boolean
C0583513 (UMLS CUI [1])
Lantus Stable status
Item
stable treatment (±20%) with lantus for 3 months or more prior to screening.
boolean
C0876064 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Sulfonylurea Dose Stable
Item
sulfonylurea dose stable for 3 months or more prior to screening
boolean
C3536898 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity Lixisenatide
Item
hypersensitivity to lixisenatide
boolean
C0020517 (UMLS CUI [1,1])
C2973895 (UMLS CUI [1,2])
Blood Glucose Uncontrolled Severe
Item
severely uncontrolled glycemic situation
boolean
C0005802 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Pancreatitis Unexplained | Pancreatitis, Chronic | Pancreatectomy | Operation on stomach | Inflammatory Bowel Disease
Item
history of unexplained pancreatitis, chronic pancreatitis, pancreatectomy, stomach/gastric surgery or inflammatory bowel disease
boolean
C0030305 (UMLS CUI [1,1])
C4288071 (UMLS CUI [1,2])
C0149521 (UMLS CUI [2])
C0030279 (UMLS CUI [3])
C0192398 (UMLS CUI [4])
C0021390 (UMLS CUI [5])
Metabolic acidosis | Diabetic Ketoacidosis
Item
history of metabolic acidosis, including diabetic ketoacidosis, within 1 year prior to screening
boolean
C0220981 (UMLS CUI [1])
C0011880 (UMLS CUI [2])
Myocardial Infarction | Cerebrovascular accident | Heart failure Requirement Hospitalization | Substance Use Disorders
Item
history within the previous 6 months of myocardial infarction, stroke or heart failure requiring hospitalization or drug or alcohol abuse
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0018801 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0019993 (UMLS CUI [3,3])
C0038586 (UMLS CUI [4])
Uncontrolled hypertension | Poor hypertension control | Systolic blood pressure at rest | Diastolic blood pressure at rest
Item
uncontrolled/inadequately controlled hypertension at the time of screening, with a resting systolic blood pressure >180 mmhg or diastolic blood pressure >95 mmhg
boolean
C1868885 (UMLS CUI [1])
C0421190 (UMLS CUI [2])
C2039694 (UMLS CUI [3])
C2183311 (UMLS CUI [4])
Serum amylase raised | Serum lipase raised | Aspartate aminotransferase increased | Alanine aminotransferase increased | Serum alkaline phosphatase raised
Item
amylase and/or lipase >3 times or aspartate aminotransferase (ast), alanine aminotransferase (alt) or alkaline phosphatase (alp) >2 times the upper limit of the normal laboratory range
boolean
C0476327 (UMLS CUI [1])
C3670924 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C1314665 (UMLS CUI [5])
Kidney Failure, Chronic | Dialysis | Gastrointestinal Diseases
Item
end-stage renal disease and/or dialysis and clinically relevant history of gastrointestinal disease
boolean
C0022661 (UMLS CUI [1])
C0011946 (UMLS CUI [2])
C0017178 (UMLS CUI [3])
Study Subject Participation Status | Considerations Additional
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial
boolean
C2348568 (UMLS CUI [1])
C0518609 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial